CDC recommends Pfizer or Moderna booster after J&J vaccine
Adults who received an initial J&J COVID-19 vaccine should receive a Pfizer or Moderna booster at least two months later for the best protection, according to a study released yesterday by the Centers for Disease Control and Prevention. The study examined 80,287 emergency department/urgent care visits and 25,244 hospitalizations in 10 states between Dec. 16, 2021, and March 7, 2022, when omicron was the predominant variant, and found adults who received a Pfizer or Moderna booster after the J&J vaccine were better protected than those who received one or two J&J doses.
Related News Articles
Headline
The Centers for Disease Control and Prevention Dec. 11 released a report that found last year’s version of the COVID-19 vaccine was 76% effective in preventing…
Headline
The Advisory Committee on Immunization Practices Sept. 19 recommended that patients should consult their health care provider if they want to receive a COVID-…
Headline
The Food and Drug Administration July 10 approved Moderna’s Spikevax COVID-19 vaccine for children under 12 with at least one underlying condition that…
Headline
Department of Health and Human Services Secretary Robert F. Kennedy Jr. May 27 announced in a post on X that the Centers for Disease Control and Prevention…
Headline
Leaders of the Food and Drug Administration May 20 announced new guidelines for administering the COVID-19 vaccine in a paper published by the New England…
Headline
The Senate Finance Committee Feb. 4 voted 14-13 to advance Robert F. Kennedy Jr.’s nomination for secretary of the Department of Health and Human Services. A…